The lowest effective dose of ropivacaine for cesarean section following labor epidural analgesia

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027527

Enrollment

Unknown

Registered

2019-11-17

Start date

2019-11-15

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstetrics

Interventions

Normal group:cesarean section following labor epidural analgesia

Preeclampsia group:cesarean section following labor epidural analgesia

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged 25 to 35 years, 50-100 kg weight, ASA I or II, 36 weeks gestation or greater, first-timer, single pregnancy, head, expand the opening of the cervix 2 ~ 3 cm

Exclusion criteria

Exclusion criteria: Prenatal use of analgesics (tramadol, demerol), sedative hypnotic history; history of neuropsychiatric disorders; high-risk pregnancy (placental abruption, placenta previa); dural rupture; epidural catheter bleeding into the blood resulted in interruption of analgesia

Design outcomes

Primary

Measure	Time frame
Ropivacaine dose;Nerve injury factors;	—

Countries

China

Contacts

Public ContactZeyong Yang

International Peace Maternal and Child Health Hospital, Shanghai Jiao Tong University School of Medicine

zeyongy2018@aliyun.com+86 13381827292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026